NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Contract Research Orgs  «  1  2  3  4  5  » 
found files: 151
PharmaLegacy Laboratories »27/10/2008 [Company watch]
PharmaLegacy, a Pre-clinical Pharmacology CRO, Opens Its Doors in Shanghai

Recently, PharmaLegacy Laboratories Co., Ltd held its Grand Opening in Shanghai’s Zhangjiang Hi-Tech Park. The CRO, which offers specialty pre-clinical pharmacology services, has expertise in the areas of oncology, bone, orthopedics, inflammation, immune disease, and PD/PK....   more»


Covance »03/11/2008 [Company watch]
Covance Taking China Growth Slowly

Following the collapse of its Joint Venture arrangement with WuXi PharmaTech (WX), Covance (CVD) will build its own China CRO facilities, but the company does not feel any great pressure to get the job done quickly. The reason? China’s current cost advantage will soon disappear, as wages for scientists in China approach those in the West, according to Joe Herring, CEO of Covance....   more»


Sundia MediTech Company,Ltd. »31/10/2008 [Company watch]
Sundia Named To Deloitte Fast 50 China

Sundia MediTech Company, a Shanghai CRO, was included in the Deloitte Technology Fast 50 China list, placing number 16. It was the second year in a row that Sundia was given the Fast 50 award. As a Fast 50 winner, Sundia will automatically be put in contention for the Deloitte Fast 500 Asia Pacific competition....   more»


Charles River »07/11/2008 [Company watch]
Charles River Says CRO Business Slowing

Charles River Labs reduced its 2008 profit guidance by 3% because its CRO clients are delaying scheduled tests until next year....   more»


Wuxi Pharma Tech »07/11/2008 [Company watch]
WuXi PharmaTech Inks New Three-year Deal with Pfizer

WuXi PharmaTech has signed a new three-year CRO deal with Pfizer to collaborate on in vitro ADME (Absorption, Distribution, Metabolism and Excretion) services....   more»


Excel PharmaStudies Inc. »28/11/2008 [Industry news]
Rural Population Key to China’s Clinical Research Market

In his presentation at China Trials 2008 in Shanghai, Mark Engel, president and chairman of Excel PharmaStudies, a large China-based contract research organization, identified two megatrends that will drive post-marketing surveillance studies to China: the rapid aging of its population and its increasingly insured rural population....   more»


Wuxi Pharma Tech »05/12/2008 [Company watch]
Wuxi cuts back

WuXi PharmaTech (Cayman) Inc., a development outsourcing company with operations in China and the United States, today announced it will dedicate its Philadelphia facility to the Company\'s expanding biologics testing, cell banking and cell therapy services,...   more»


Bioduro »11/12/2008 [Company watch]
BioDuro Labs Accredited by AAALAC

BioDuro, a CRO headquartered in San Diego, CA, but with its laboratories in Beijing, China, announced that it has been awarded full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC). The same accreditation has been given to the labs of the National Center for Safety Evaluation of Drugs (NCSED), with whom BioDuro has an exclusive collaboration....   more»


Wuxi Pharma Tech »06/01/2009 [Company watch]
WuXi AppTec Selects H-Cube From Thalesnano For Laboratory-Based Hydrogenation

WuXi thus joins all the top 20 pharmaceutical companies worldwide that have introduced and adopted the H-Cube technology....   more»


MDS Pharma Services »16/01/2009 [Company watch]
MDS Pharma appoints Dr Jessica Liu to lead clinical operations in Asia

MDS Pharma has appointed Dr Jessica Liu, to the position of Clinical Operations Director and Head of the Asia-Pacific region for its late-stage clinical trial management division. The appointment supports the MDS business unit’s well-established and growing presence there and strengthens its ability to serve clients in an increasingly important emerging geography....   more»


Wuxi Pharma Tech »18/01/2009 [Company watch]
WuXi Gains From Pfizer\'s Loss

On Tuesday last week, the world\'s largest drug maker announced it would be eliminating 800 positions from its research and development rolls. It was bad news for laboratories in St. Louis, Groton, Conn., La Jolla, Calif. and Sandwich, England, where the cuts were made. For China-based WuXi PharmaTech (Cayman) Inc. (WX), however, the implications are anything but negative....   more»


Sundia MediTech Company,Ltd. »11/02/2009 [Company watch]
Zhangjiang Park and CRO Sundia MediTech Form Incubator

Shanghai Zhangjiang (Group) Co., which operates the Zhangjiang Hi-Tech Park, has joined with CRO Sundia MediTech Company to expand the concept of a CRO....   more»


Sundia MediTech Company,Ltd. »11/02/2009 [Company watch]
Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List

Sundia MediTech, a pharmaceutical R&D outsourcing service company in China, was selected in Deloitte Technology Fast 500 Asia Pacific list....   more»


Wuxi Pharma Tech »18/02/2009 [Company watch]
WuXi PharmaTech\'s CFO leaves company

Chinese R&D outsourcing company, WuXi PharmaTech has announced that Mr Benson Tsang, Chief Financial Officer, is leaving the company for personal reasons by the end of February. Mr Edward Hu, Chief Operating Officer, will serve as acting Chief Financial Officer until a replacement is found....   more»


Charles River »23/02/2009 [Company watch]
Charles River Stock under Pressure

The stock has been under pressure lately due to investor concerns that drug companies will trim research and development expenses, and that industry consolidation would thin the company\'s customer base...   more»


Wuxi Pharma Tech »30/03/2009 [Company watch]
WuXi PharmaTech\'s revenue touches $268 mn in 2008

WuXi PharmaTech, a leading research and development outsourcing company, with operations in China and the US, announced that its total full-year 2008 net revenues stood at $261.8 million, which include $253.5 million from continuing operations and $8.3 million from discontinued operations....   more»


Wuxi Pharma Tech »25/03/2009 [Company watch]
WuXi AppTec appoints three senior professionals

WuXi AppTec, a pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced the addition of three key senior professionals....   more»


Wuxi Pharma Tech »01/04/2009 [Company watch]
WuXi AppTec bioanalytical services unit passes FDA inspection

China WuXi AppTec said its Bioanalytical Services unit had been inspected by the Food and Drug Administration without the issuance of a Form 483, which is used to report any non compliance issues after a site inspection....   more»


MDS Pharma Services »12/04/2009 [Company watch]
MDS Pharma Services Appoints Dr. Ping Li Laboratory Director for Beijing Central Lab

The appointment of the widely known and highly regarded Dr. Li supports the contract research organizations well-established and growing presence in China and the broader Asia-Pacific region, and strengthens its ability to serve clients in an increasingly important geographic area....   more»


Covance »09/04/2009 [Company watch]
Covance Central Laboratory Receives CAP Accreditation in China

Covance Inc. today announced that the companys Shanghai, China central laboratory has achieved accreditation by the College of American Pathologists (CAP)....   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.